ALFA Filings
Every announcement, straight from the exchange
Every regulatory approval announcement on NSE and BSE that our alert engine sent, newest first.
Time
353 announcements with these filters
IndusInd Bank has received RBI approval to establish a wholly-owned subsidiary for stockbroking operations and infuse equity capital into the entity.
Real Touch Finance received RBI approval to appoint Mr. Angalappan Anandakumar as a Director. However, the RBI rejected the proposed appointments of two other directors.
Zydus Lifesciences received final USFDA approval for Indocyanine Green for Injection with 180-day exclusivity. The reference brand had annual U.S. sales of approximately USD 125.8 million.
Delhivery Limited's wholly owned subsidiary, Delhivery Financial Services Private Limited, received a Type II NBFC-ND Certificate of Registration from the Reserve Bank of India.
360 ONE WAM's subsidiary, 360 ONE Global Asset Management (IFSC) Limited, received a Certificate of Registration from the IFSCA to operate as a Fund Management Entity.
Paul Merchants received RBI approval for its Authorised Dealer Category-II licence renewal, granting perpetual validity instead of annual renewals for its money-changing business.
WSFx Global Pay Limited received a perpetual Authorised Dealer Category-II licence from the RBI. This expands their scope of operations in cross-border payments and forex business.
MAS Financial Services received UIDAI approval to act as a Sub-Authentication User Agency and Sub-eKYC User Agency for Aadhaar-based authentication services.
SEBI has granted PGInvIT relaxation from corporate governance norms regarding independent directors and unitholder nominee director rights. These exemptions remain effective until late 2026.
Cube Highways Trust has received approval to convert from a privately listed InvIT to a publicly listed InvIT, effective July 31, 2026. This change subjects the Trust to public listing regulations.
Fischer Medical Ventures secured CDSCO regulatory clearance to import and distribute the Spincare Portable Wound Care System. This marks India's first approval for a portable electrospun wound system.
Biocon received Health Canada approval for its Yesintek (ustekinumab) Autoinjector Pen. This new product format expands the company's immunology portfolio in Canada.
AstraZeneca Pharma India Limited received CDSCO approval to import and market Enhertu for an additional breast cancer indication. This regulatory milestone enables the treatment's use for HER2-positive adult patients.
Cipla received U.S. FDA approval for its Generic Advair Diskus. The product is expected to launch in the U.S. market in Q2 FY 2026-27.
Sattrix Information Security received a Certificate of Membership from CREST International Limited. This approval recognizes the company's technical expertise and standards in cybersecurity.
Vedanta Oil and Gas Limited received a 'No Objection' from the Ministry of Petroleum and Natural Gas for the assignment of oil and gas block interests.
AvenuesAI Limited received authorization from the Reserve Bank of India to issue and operate Prepaid Payment Instruments (PPIs) in India.
Kwality Pharmaceuticals received CDSCO approval to manufacture pilot batches of Pembroluzimab. This progresses the biologics product from research to the pre-clinical stage.
Shiva Cement has received 'Consent to Operate' from the Odisha State Pollution Control Board for its Khatkurbahal (North) Block limestone and dolomite mines.
EbixCash, a subsidiary of Ebix Ltd, received RBI approval to undertake trade remittances, expanding the scope of its existing AD-II license for cross-border payments.
Aurobindo Pharma's subsidiary, CuraTeQ Biologics, received ANVISA (Brazil) approval for its biosimilars manufacturing facility in Hyderabad. This approval enables supply to Brazilian and Latin American markets.
Glenmark received U.S. FDA approval to expand the use of its RYALTRIS nasal spray to pediatric patients aged 6 to less than 12 years.
Emcure received CDSCO approval to expand the use of its drug Poviztra for treating MASH. This milestone allows the company to address a significant unmet medical need.
Natco Pharma received tentative U.S. FDA approval for Olaparib tablets. The reference drug Lynparza reported USD 1.4 billion in U.S. sales.
RBI approved re-appointing Chokshi & Chokshi LLP and Borkar & Muzumdar as Joint Statutory Auditors for FY 2026-27. This ensures regulatory compliance for IndusInd Bank.
AstraZeneca Pharma India received CDSCO approval to market Benralizumab (Fasenra) for treating Hypereosinophilic Syndrome. This regulatory clearance expands the drug's therapeutic indications in the Indian market.
Shivalik Bimetal Controls received Consent to Operate for its Pune Facility (Phase-I) from MPCB. This regulatory approval allows the company to proceed with operations at the site.
Anand Rathi Wealth's subsidiary received in-principle IFSCA approval for Fund Management Entity registration at GIFT City. Operations commencement remains subject to final registration.
Desco Infratech received a five-year Electrical Contractor's Licence from the Government of Gujarat. This approval enables the company to execute electrical installation projects across the state.
Biocon received EMA approval for a new insulin fill finish line in Malaysia. Supplies to the European market are expected to commence from Q2FY27.